-
公开(公告)号：US20200146325A1
公开(公告)日：2020-05-14
申请号：US16231200
申请日：2018-12-21
发明人： Yong Wu , Wei Cao , Jieqing Li , Huabing Yang , Ke Wu , Shiliu Tian
IPC分类号： A23L33/105 , A23L33/15 , A23L33/16 , A61K36/481 , A61K36/73 , A61K36/605 , A61K36/63 , A61K36/42 , A61K31/4188 , A61K31/375 , A61K9/00 , A61P3/10
摘要： A formulation for a dietary supplement includes standardized extracts of astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.
-
公开(公告)号：US11266668B2
公开(公告)日：2022-03-08
申请号：US16792109
申请日：2020-02-14
发明人： Yong Wu , Wei Cao , Jieqing Li , Huabing Yang , Ke Wu , Shiliu Tian
IPC分类号： A61K31/7034 , A61K36/605 , A61K36/63 , A61K36/42 , A61P3/10 , A61K31/375 , A61K33/24 , A61K31/593 , A61K9/00 , A61K31/4188
摘要： A formulation for a dietary supplement includes standardized extracts of astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.
-
公开(公告)号：US11135259B2
公开(公告)日：2021-10-05
申请号：US16239475
申请日：2019-01-03
发明人： Yong Wu , Ke Wu , Gordon Lee , Wei Cao , Huabing Yang
IPC分类号： A61K36/296 , A61K36/63 , A61P15/10 , A61K36/88 , A61K31/133 , A61K31/4406 , A61K36/185 , A61K31/385 , A61K36/258 , A61K36/889 , A61K33/06 , A61K33/30 , A61K36/31 , A61K36/899 , A61K31/185 , A61K31/198 , A61K31/352
摘要： Compositions for improving erectile function or treating erectile dysfunction include active ingredients of Muira Puama extract, Quercetin, Chlorophytum borivilianum (Safed Musli), Dimethylethanolamine (DMAE), niacin, Tribulus terrestris extract, alpha-lipoic acid, Horny Goat Weed (Epimedium grandfiflorum), Panax ginseng, and saw palmetto berry extract, and may also include magnesium aspartate, Zinc oxide, and Maca root (Lepidium meyenii). Additional active ingredients include Avena sativa extract (oat straw), L-Taurine, L-Lysine hydrochloride (HCl), a L-Arginine, and/or L-Carnitine.
-
公开(公告)号：US10757961B2
公开(公告)日：2020-09-01
申请号：US16231200
申请日：2018-12-21
发明人： Yong Wu , Wei Cao , Jieqing Li , Huabing Yang , Ke Wu , Shiliu Tian
IPC分类号： A61K31/375 , A23L33/105 , A23L33/16 , A61K36/481 , A61K36/73 , A61K36/605 , A61K36/63 , A61K36/42 , A61K31/4188 , A61K9/00 , A61P3/10 , A23L33/15
摘要： A formulation for a dietary supplement includes standardized extracts of Astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
